Upper respiratory tract infections Rasool Soltani, Pharm.D., BCPS Assistant professor of Clinical Pharmacy Isfahan University of Medical Sciences

Embed Size (px)

Citation preview

  • Slide 1
  • Upper respiratory tract infections Rasool Soltani, Pharm.D., BCPS Assistant professor of Clinical Pharmacy Isfahan University of Medical Sciences
  • Slide 2
  • Upper respiratory tract infections Otitis media Sinusitis Pharyngitis Laryngitis (croup) Epiglottitis
  • Slide 3
  • Upper respiratory tract infections responsible for the majority of antibiotics prescribed in ambulatory practice
  • Slide 4
  • Acute Otitis Media (AOM)
  • Slide 5
  • Otitis media inflammation of the middle ear most common in infants and children
  • Slide 6
  • Slide 7
  • Slide 8
  • Risk factors Winter season/outbreaks of respiratory syncytial or influenza virus Attendance at day care centers Lack of breast-feeding in infants Early age of first diagnosis Genetic predisposition Siblings in the home
  • Slide 9
  • Risk factors Cleft palate Lower socioeconomic status Exposure to tobacco smoke Use of a pacifier Bottle feeding Male gender Immunodeficiency Allergy
  • Slide 10
  • Pathophysiology usually follows a viral upper respiratory tract infection eustachian tube dysfunction and mucosal swelling in the middle ear Entry of colonized bacteria to the middle ear Impairment of clearance by the mucociliary system Proliferation of bacteria
  • Slide 11
  • Pathogens Streptococcus pneumoniae (20% to 35%) Haemophilus influenzae (20% to 30%) Moraxella catarrhalis (20%)
  • Slide 12
  • Clinical presentation The acute onset of signs and symptoms of middle ear infection following cold symptoms of runny nose, nasal congestion, or cough
  • Slide 13
  • Clinical presentation Symptoms Pain that can be severe (more than 75% of patients) Fever (less than 25% of patients) Children: irritable, difficult sleeping Signs Discolored (gray), thickened, bulging eardrum Pneumatic otoscopy demonstrates an immobile eardrum Draining middle ear fluid (less than 3% of patients)
  • Slide 14
  • Slide 15
  • Slide 16
  • Laboratory tests Gram stain Culture
  • Slide 17
  • Diagnosis
  • Slide 18
  • Treatment Acetaminophen or NSAIDs to relieve pain and malaise Surgical insertion of tympanostomy tubes (T tubes) For children who have at least three episodes in 6 months
  • Slide 19
  • First LinePenicillin AllergyTreatment Failure Amoxicillin high dose 8090 mg/kg/day divided twice daily If severe symptoms (severe otalgia and T > 39C ) Amoxicillin-clavulanate Ceftriaxone (1-3 days) Cefuroxime 30 mg/kg/day divided twice daily Cefixime 8 mg/kg/day Azithromycin 10 mg /kg /day 1, then 5 mg /kg /day for days 25 Clarithromycin 15 mg /kg /day divided twice daily Co-trimoxazole 8 mg/kg/day TMP divided twice daily Amoxicillin-clavulanate Ceftriaxone 50 mg /kg/day IM/IV for 3 days Alternatives: Clindamycin 3040 mg/kg /day in 3 divided doses Tympanocentesis
  • Slide 20
  • Antibiotic Prophylaxis of Recurrent Infections at least three episodes in 6 months or at least four episodes in 12 months risk of hearing loss and language and learning disabilities in children younger than 3 years of age
  • Slide 21
  • Vaccination Influenza vaccine Pneumococcal vaccine Children ages 2 to 23 months Patients with recurrent otitis media
  • Slide 22
  • Sinusitis
  • Slide 23
  • inflammation and/or infection of the paranasal sinus mucosa Rhinosinusitis Majority of cases are viral.
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Sinusitis Viral: resolve by 7 to 10 days Bacterial: persistence of symptoms beyond this time or worsening of symptoms likely indicates this type.
  • Slide 29
  • Bacterial sinusitis Acute: lasts less than 30 days Chronic: lasts more than 3 months
  • Slide 30
  • Pathophysiology usually follows a viral respiratory tract infection mucosal inflammation obstruction of the sinus ostia Mucosal secretions become trapped local defenses are impaired Proliferation of bacteria from adjacent surfaces
  • Slide 31
  • Pathogens Viruses (most cases) S. pneumoniae H. influenzae M. catarrhalis
  • Slide 32
  • Clinical presentation: acute Nasal congestion Nasal discharge Maxillary tooth pain Facial or sinus pain that may radiate (unilateral in particular) Facial pressure Fever Fatigue Cough Hyposmia or anosmia Ear pressure or fullness Headache Halitosis
  • Slide 33
  • Indications for referral Abnormal vision (diplopia, blindness) Change in mental status Periorbital edema
  • Slide 34
  • Clinical presentation: chronic Symptoms are similar to acute sinusitis but more nonspecific Chronic unproductive cough and headache may occur Rhinorrhea is associated with acute exacerbations Hyposmia o Chronic/recurrent infections occur three to four times a year
  • Slide 35
  • Complications Osteomylitis Cellulitis of the orbit Abscess Meningitis
  • Slide 36
  • Orbital abscess
  • Slide 37
  • Diagnosis Purulent rhinorrhea Nasal congestion Facial pain/pressure Radiologic tests For differential diagnosis when sinusitis is not clearly suspected In complicated sinusitis In recurrent or treatment-resistant sinusitis
  • Slide 38
  • Symptoms suggestive of bacterial cause 1.onset with persistent symptoms or signs, lasting at least 10 days without evidence of clinical improvement 2.onset with severe symptoms or signs of high fever (39 C) and purulent nasal discharge lasting for 3 to 4 consecutive days 3.onset with worsening symptoms or signs
  • Slide 39
  • Supportive treatment Acetaminophen and NSAIDs Nasal irrigation Nasal corticosteroids Topical decongestants Mucolytics
  • Slide 40
  • Antibiotic therapy Uncomplicated Sinusitis Uncomplicated sinusitis, penicillin- allergic patient Treatment failure, prior antibiotic therapy in past 4 to 6 weeks, 10% nonsusceptible pneumococci, attendance at day care, age younger than 2 years or older than 65 years, recent hospitalization Amoxicillin Doxycycline Respiratory fluoroquinolone High-dose amoxicillin High-dose amoxicillin/clavulanate Cephalosporin Respiratory fluoroquinolone
  • Slide 41
  • Antibiotic therapy Failure of high-dose amoxicillin/clavulanate: Respiratory FQ Cefixime + clindamycin or linezolid Neither azithromycin nor clarithromycin have adequate coverage for H. influenzae and S. pneumoniae
  • Slide 42
  • Slide 43
  • Duration of therapy 10 to 14 days or at least 7 days after symptoms are under control
  • Slide 44
  • Treatment failure: Persistence or worsening of symptoms 72 hours after initiating antimicrobial therapy
  • Slide 45
  • Treatment of chronic rhinosinusitis Antibiotics (aerobes and anaerobes) Nasal corticosteroids Nasal irrigation
  • Slide 46
  • Monotherapy Amoxicillin-clavulanate children: 45 mg/kg/day divided every 12 hours adults: 500 mg three times daily Clindamycin children: 20 to 40 mg/kg/day orally divided every 6 to 8 hours adults: 300 mg four times daily or 450 mg three times daily Moxifloxacin 400 mg once daily generally in adults only
  • Slide 47
  • Two-drug regimens Metronidazole, PLUS one of the following: Cefuroxime Levofloxacin Azithromycin Clarithromycin Trimethoprim-sulfamethoxazole
  • Slide 48
  • Duration At least 3 weeks (up to 10 weeks in refractory cases)
  • Slide 49
  • Follow-up Culture: preferably directly from the sinus cavity in patients who fail to have significant improvement or who demonstrate signs of deterioration despite therapy
  • Slide 50
  • Pharyngitis
  • Slide 51
  • an acute infection of the oropharynx or nasopharynx the reason for 1% to 2% of all outpatient visits
  • Slide 52
  • Slide 53
  • Slide 54
  • Pathogens Viruses (the most common) group A Streptococcus or S. pyogenes (10% to 30%)
  • Slide 55
  • Signs and Symptoms Sore throat Pain on swallowing Fever Headache, nausea, vomiting, and abdominal pain (especially children) Erythema/inflammation of the tonsils and pharynx with or without patchy exudates Enlarged, tender lymph nodes Red swollen uvula, petechiae on the soft palate
  • Slide 56
  • Slide 57
  • Slide 58
  • Slide 59
  • Several symptoms that are not suggestive of group A Streptococcus: Cough Conjunctivitis Coryza Diarrhea
  • Slide 60
  • Slide 61
  • Slide 62
  • Slide 63
  • Diagnosis Testing for presence of bacteria: Culture Rapid antigen-detection test (RADT)
  • Slide 64
  • Slide 65
  • Slide 66
  • Treatment (adult) DrugAdult dosageDuration Penicillin VK250 mg three or four times daily or 500 mg twice daily 10 days Penicillin benzathine1.2 million units intramuscularlyOne dose Amoxicillin500 mg three times daily10 days Erythromycin40 mg/kg/day divided two to four times daily (max: 1 g/day) 10 days Cephalexin250500 mg orally four times daily10 days
  • Slide 67
  • Treatment (children)